BackGlycoMimetics Overview

GlycoMimetics Current Assets

Track GlycoMimetics's current assets ($200M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$195.56M
↓ 96.74% YoYΔ $-5.80B vs prior year quarter

Peer average

Loading

GlycoMimetics Current Assets History

Loading

GlycoMimetics vs. peers: Current Assets Comparison

Loading

GlycoMimetics Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

GlycoMimetics (GLYC) FAQ

GlycoMimetics (GLYC) currently reports a current assets of $200M as of March 2026. That compares with $6B in the prior-year period — down 96.7% year over year. Use the charts on this page to explore GlycoMimetics's current assets history and peer comparisons.

GlycoMimetics's current assets decreased from $6B to $200M — a 96.7% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

GlycoMimetics reported $200M in current assets as of March 2026. That compares with $6B in the prior-year period — down 96.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $200M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for GlycoMimetics, and consider following GLYC for alerts when major investors trade the stock.

GlycoMimetics is classified in the Healthcare sector. On current assets, it currently shows $200M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing GLYC with unrelated industries.